… Antiestrogen endocrine therapies such as letrozole and tamoxifen can … This study demonstrated
the important role the sonic … In a phase II clinical trial of brentuximab vedotin, 11% of the …

… carmustine, cisplatin, cytarabine, 5-fluorouracil, ifosfamide, thiotepa, interleukin-2, and interferon
alpha… busulfan, doxorubicin, dacarbazine, fludarabine, and cabazitaxel treatment, but is …

… the MTD is recommended for Phase II studies. It is noteworthy that … positive studies reveal
responses when interferon alpha is … power, but Cisplatin and Dacarbazine are the ones that …

… (patient number 1 and 2 in Table 2) did not have LNM. With regard to adjuvant therapy,
three patients received intravenous interferon-alpha (IFN-α) and two patients received adjuvant …

… These include dacarbazine, cisplatin (a … 10]), tamoxifen (a nonsteroidal selective estrogen
receptor modulator that binds and inhibits the function of estrogen receptor), and carmustine (a …

… regimen’ (Cisplatin, Dacarbazine, Tamoxifen and Carmustine), … , iv treatment with bolus
high-dose interferon alpha 2b for … Through performance of a pilot phase II clinical trial, our group …

… Of all the types of skin cancer, melanoma has the worst prognosis and it is considered to
have the highest metastatic potential. Skin melanoma is one of the most spread type of all …

… agent in the treatment of advanced stages of melanoma. INF-β … docetaxel prodrug (DTXp)
and cisplatin (DDP) as noted from … -phase, phase I, phase II, phase III to phase IV. All of these …

… The highly curable stage one is considered as a localized form of melanoma, stage two is
also a localized … loaded the cisplatin and a combination of cisplatin-metformin on cubosomes …

… , SCC, and melanoma making up a considerable portion—but also include unique entities
such as rhabdomyosarcoma, adenocarcinoma, lymphoma, and metastasis or direct invasion …